No black box warning on record for Glimepiride

As of the latest FDA labeling reviewed, Glimepiride (GLIMEPIRIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Glimepiride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypoglycemia: May be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications ( 5.1 ). Hypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. If a reaction is suspected, promptly discon

No black box warning on record for Glimepiride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypoglycemia: May be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications ( 5.1 ). Hypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. If a reaction is suspected, promptly discon

Glimepiride Black Box Warning

No black box warning on record for Glimepiride

Other warnings & precautions

Glimepiride Black Box Warning

No black box warning on record for Glimepiride

Other warnings & precautions